Guan, X., Wang, L., Cao, Y., Shi, F., Xu, H., Ding, J., Wu, M. and Li, H. (2023) “A Erratum on Cost effectiveness analysis of blonanserin versus ziprasidone as first-line treatment for patients with schizophrenia in China”, Health Decision, 1. doi: 10.54844/hd.2023.0498.